Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo E Rodriguez

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2013
Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the dataAlfredo E Rodriguez
Expert Opinion on Emerging Drugs|August 29, 2009
Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent eraAlfredo E Rodriguez
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Coronary artery bypass surgery or coronary stenting in diabetic patients: too soon to make a statement?Alfredo E Rodriguez
Recent Patents on Cardiovascular Drug Discovery|November 11, 2008
Systemic immunosuppressive therapy with oral Sirolimus after bare metal stent implantation: the missing alternative in the prevention of coronary restenosis after percutaneous coronary interventionsAlfredo E Rodriguez, Carlos Fernandez-Pereira
Clinical Medicine Insights. Cardiology|December 17, 2016
Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year JourneyAlfredo E Rodriguez, Hernán Pavlovsky, Juan Francisco Del Pozo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Late stent thrombosis: the Damocle's sword of drug eluting stents?Alfredo E Rodriguez, Gaston A Rodriguez-Granillo, Igor F Palacios
World Journal of Cardiology|April 19, 2011
Advantages and disadvantages of biodegradable platforms in drug eluting stentsAgustina Rodriguez-Granillo, Bibiana Rubilar, Gaston Rodriguez-Granillo, et al.
The International Journal of Cardiovascular Imaging|November 13, 2009
Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiographyGastón A Rodríguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
Current Cardiology Reports|February 22, 2017
Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 10, 2015
Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV StudyAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2013
Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the dataAlfredo E Rodriguez
Expert Opinion on Emerging Drugs|August 29, 2009
Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent eraAlfredo E Rodriguez
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Coronary artery bypass surgery or coronary stenting in diabetic patients: too soon to make a statement?Alfredo E Rodriguez
Recent Patents on Cardiovascular Drug Discovery|November 11, 2008
Systemic immunosuppressive therapy with oral Sirolimus after bare metal stent implantation: the missing alternative in the prevention of coronary restenosis after percutaneous coronary interventionsAlfredo E Rodriguez, Carlos Fernandez-Pereira
Clinical Medicine Insights. Cardiology|December 17, 2016
Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year JourneyAlfredo E Rodriguez, Hernán Pavlovsky, Juan Francisco Del Pozo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Late stent thrombosis: the Damocle's sword of drug eluting stents?Alfredo E Rodriguez, Gaston A Rodriguez-Granillo, Igor F Palacios
World Journal of Cardiology|April 19, 2011
Advantages and disadvantages of biodegradable platforms in drug eluting stentsAgustina Rodriguez-Granillo, Bibiana Rubilar, Gaston Rodriguez-Granillo, et al.
The International Journal of Cardiovascular Imaging|November 13, 2009
Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiographyGastón A Rodríguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
Current Cardiology Reports|February 22, 2017
Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 10, 2015
Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV StudyAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Pageof 6